Atle Fund Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001381843 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Jul 14, 2025

Total Value: $234M (100.0% shares, 0.0% debt)

Holdings (37)

LLY Eli Lilly & Co 12.9%
Value $30.18M Shares 38,721 Est. Cost $707.31 Unrealized +9.3%
ABBV AbbVie Inc 6.9%
Value $16.14M Shares 86,933 Est. Cost $165.02 Unrealized +10.7%
BSX Boston Scientific Corp 5.8%
Value $13.55M Shares 126,185 Est. Cost $68.73 Unrealized +47.2%
NBIX Neurocrine Biosciences Inc 4.8%
Value $11.11M Shares 88,392 Est. Cost $130.08 Unrealized -11.8%
MRK Merck & Co. Inc 4.7%
Value $11.02M Shares 139,172 Est. Cost $102.80 Unrealized -24.7%
SYK Stryker Corporation 4.7%
Value $10.87M Shares 27,466 Est. Cost $317.70 Unrealized +16.9%
VRTX Vertex Pharmaceuticals Inc 4.6%
Value $10.83M Shares 24,328 Est. Cost $420.60 Unrealized +9.6%
ISRG Intuitive Surgical Inc 4.3%
Value $10.09M Shares 18,559 Est. Cost $547.80 Unrealized -4.6%
TMO Thermo Fisher Scientific Corp 4.2%
Value $9.839M Shares 24,266 Est. Cost $520.55 Unrealized -19.9%
COR Cencora Inc 4.0%
Value $9.435M Shares 31,466 Est. Cost $208.00 Unrealized +37.9%
GILD Gilead Sciences Inc 3.5%
Value $8.112M Shares 73,165 Est. Cost $100.53 Unrealized +3.8%
BBIO Bridgebio Pharma Inc 3.1%
Value $7.145M Shares 165,480 Est. Cost $30.36 Unrealized +19.8%
AMGN Amgen Inc 2.9%
Value $6.671M Shares 23,894 Est. Cost $267.21 Unrealized +4.0%
ALKS Alkermes PLC 2.8%
Value $6.501M Shares 227,224 Est. Cost $26.53 Unrealized +12.2%
ONC BeiGene Ltd 2.5%
Value $5.903M Shares 24,386 Est. Cost $233.86 Unrealized
MIRM Mirum Pharmaceuticals Inc 2.3%
Value $5.441M Shares 106,912 Est. Cost $36.30 Unrealized +22.6%
UFPT UFP Technologies Inc 2.3%
Value $5.344M Shares 21,886 Est. Cost $280.66 Unrealized -19.8%
CAH Cardinal Health Inc 1.9%
Value $4.502M Shares 26,797 Est. Cost $68.32 Unrealized +115.3%
EW Edwards Lifesciences Corp 1.9%
Value $4.486M Shares 57,360 Est. Cost $73.91 Unrealized +0.9%
VERONA PHARMA PLC - ADR 1.9%
Value $4.455M Shares 47,100 Est. Cost $71.68 Unrealized
DXCM Dexcom Inc 1.9%
Value $4.441M Shares 50,872 Est. Cost $97.28 Unrealized -19.4%
IRTC iRhythm Technologies Inc 1.7%
Value $3.895M Shares 25,302 Est. Cost $110.30 Unrealized +17.2%
SLNO Soleno Therapeutics Inc 1.5%
Value $3.396M Shares 40,532 Est. Cost $50.72 Unrealized +47.6%
Merus N.V. 1.3%
Value $3.15M Shares 59,889 Est. Cost $45.53 Unrealized
RVMD REVOLUTION Medicines Inc 1.3%
Value $3.027M Shares 82,275 Est. Cost $46.47 Unrealized -17.3%
NAMS NewAmsterdam Pharma Co NV 1.2%
Value $2.847M Shares 157,223 Est. Cost $18.65 Unrealized -2.2%
KRYS Krystal Biotech, Inc 1.2%
Value $2.771M Shares 20,158 Est. Cost $153.47 Unrealized -4.3%
HRMY HARMONY BIOSCIENCES HLDGS IN 1.2%
Value $2.726M Shares 86,274 Est. Cost $33.61 Unrealized -4.3%
AUTL Autolus Therapeutics PLC 1.1%
Value $2.52M Shares 1,105,461 Est. Cost $3.05 Unrealized
UNH Universal Health Services Inc 1.1%
Value $2.487M Shares 13,727 Est. Cost $502.95 Unrealized -25.5%
MREO Mereo Biopharma Group PLC 0.9%
Value $2.073M Shares 764,901 Est. Cost $3.28 Unrealized
SMMT Summit Therapeutics Inc 0.8%
Value $1.973M Shares 92,737 Est. Cost $14.99 Unrealized +52.1%
ACLX Arcellx Inc 0.7%
Value $1.694M Shares 25,732 Est. Cost $60.03 Unrealized +3.7%
BCAX BICARA THERAPEUTICS INC 0.6%
Value $1.369M Shares 147,380 Est. Cost $13.02 Unrealized -8.5%
IRON Disc medicine inc 0.6%
Value $1.306M Shares 24,652 Est. Cost $46.97 Unrealized 0.0%
CRBP Corbus Pharmaceuticals Holding 0.5%
Value $1.212M Shares 175,582 Est. Cost $20.42 Unrealized -64.4%
JANX Janux Therapeutics Inc 0.5%
Value $1.151M Shares 49,820 Est. Cost $49.08 Unrealized -46.3%